Stock listing
NASDAQ:RYTM Rhythm Pharmaceuticals, Inc. Stock
Home listing (NASDAQ) of Rhythm Pharmaceuticals, Inc.
Follow Rhythm Pharmaceuticals, Inc. into a list and get an email when it puts out news.
Share price · NASDAQ:RYTM
$112.36 USD -6.68 (-5.6%)
Close on Nov 20, 2026
- Day range
- $112.00 – $117.01 USDNov 20, 2026
- Volume
- 1.50M sharesNov 20, 2026
- Market cap
- $7.79B USDAt the close on Nov 20, 2026 · price × 69.33M shares outstanding
- 52-week range
- $74.50 – $122.20 USDLowest and highest trades, Nov 21, 2025 – Nov 20, 2026
- Traded on an average day
- $109.2M USDMedian day 644,600 shares · last 3 months, Aug 20, 2026 – Nov 20, 2026

Prices by listing
| Listing | Last | Change | Volume | Open | High | Low | Previous close | Price from |
|---|---|---|---|---|---|---|---|---|
| NASDAQ:RYTM · Home | $112.36 USD | -6.68 (-5.6%) | 1,502,362 | $115.46 | $117.01 | $112.00 | $119.04 | Close on Nov 20, 2026 |
| Frankfurt:1RV | €100.00 EUR | -2.00 (-2.0%) | — | €105.00 | €105.00 | €100.00 | €102.00 | Close on Nov 20, 2026 |
Daily closes
Last 3 months, Aug 20, 2026 – Nov 20, 2026 · NASDAQ:RYTM · USD, adjusted for splits
| Day | Close | Change | % | Open | High | Low | Volume |
|---|---|---|---|---|---|---|---|
| $112.36 | -6.68 | -5.6% | $115.46 | $117.01 | $112.00 | 1,502,362 | |
| $119.04 | +2.43 | +2.1% | $115.72 | $121.41 | $114.59 | 2,014,530 | |
| $116.61 | +9.13 | +8.5% | $106.81 | $118.50 | $104.20 | 2,563,407 | |
| $107.48 | -7.54 | -6.6% | $113.23 | $114.93 | $107.21 | 947,267 | |
| $115.02 | +5.16 | +4.7% | $109.81 | $117.84 | $107.86 | 1,144,113 | |
| $109.86 | -2.30 | -2.1% | $112.26 | $112.26 | $108.94 | 1,054,918 | |
| $112.16 | -1.79 | -1.6% | $113.76 | $115.20 | $112.04 | 734,161 | |
| $113.95 | +0.01 | 0.0% | $113.42 | $115.06 | $112.51 | 616,028 | |
| $113.94 | +1.66 | +1.5% | $112.30 | $114.98 | $110.78 | 1,286,798 | |
| $112.28 | +7.26 | +6.9% | $107.10 | $113.29 | $104.31 | 4,928,737 | |
| $105.02 | -5.66 | -5.1% | $108.76 | $110.66 | $103.06 | 6,396,436 | |
| $110.68 | +24.24 | +28.0% | $85.94 | $110.68 | $85.04 | 5,489,582 | |
| $86.44 | -7.00 | -7.5% | $84.83 | $89.28 | $81.58 | 7,110,007 | |
| $93.44 | +0.87 | +0.9% | $93.13 | $95.35 | $92.40 | 2,003,953 | |
| $92.57 | -0.50 | -0.5% | $93.48 | $95.60 | $91.42 | 431,700 | |
| $93.07 | +1.10 | +1.2% | $93.00 | $94.16 | $92.52 | 760,500 | |
| $91.97 | -0.21 | -0.2% | $91.37 | $92.70 | $91.05 | 533,900 | |
| $92.18 | +2.71 | +3.0% | $89.36 | $92.72 | $88.72 | 400,200 | |
| $89.47 | +0.20 | +0.2% | $90.07 | $90.81 | $89.00 | 289,400 | |
| $89.27 | -1.63 | -1.8% | $90.44 | $90.44 | $88.56 | 536,900 | |
| $90.90 | +2.28 | +2.6% | $88.85 | $90.95 | $87.59 | 516,400 | |
| $88.62 | -1.58 | -1.8% | $91.02 | $92.18 | $88.12 | 511,300 | |
| $90.20 | +1.97 | +2.2% | $88.56 | $91.88 | $88.56 | 877,000 | |
| $88.23 | +2.06 | +2.4% | $87.04 | $88.76 | $86.59 | 378,800 | |
| $86.17 | -1.80 | -2.0% | $88.20 | $88.62 | $85.91 | 367,000 | |
| $87.97 | +1.26 | +1.5% | $88.41 | $90.42 | $87.61 | 644,600 | |
| $86.71 | +0.10 | +0.1% | $86.41 | $88.14 | $85.38 | 585,800 | |
| $86.61 | -3.21 | -3.6% | $89.63 | $90.51 | $86.35 | 623,000 | |
| $89.82 | -0.96 | -1.1% | $91.05 | $91.42 | $89.49 | 543,800 | |
| $90.78 | +1.14 | +1.3% | $89.67 | $93.35 | $89.41 | 1,411,400 | |
| $89.64 | +1.19 | +1.3% | $89.05 | $90.94 | $87.01 | 1,008,500 | |
| $88.45 | -2.32 | -2.6% | $90.77 | $91.37 | $88.23 | 939,400 | |
| $90.77 | -1.68 | -1.8% | $92.55 | $94.47 | $90.07 | 992,900 | |
| $92.45 | -0.38 | -0.4% | $93.95 | $94.41 | $89.53 | 1,027,200 | |
| $92.83 | -0.58 | -0.6% | $94.97 | $95.32 | $92.66 | 503,500 | |
| $93.41 | -1.805 | -1.9% | $95.34 | $96.48 | $93.00 | 850,600 | |
| $95.22 | -0.495 | -0.5% | $96.67 | $97.37 | $95.10 | 737,200 | |
| $95.71 | -2.85 | -2.9% | $97.92 | $98.91 | $94.51 | 810,900 | |
| $98.56 | -0.10 | -0.1% | $98.01 | $99.15 | $95.27 | 897,400 | |
| $98.66 | +0.35 | +0.4% | $98.41 | $99.45 | $96.35 | 864,300 | |
| $98.31 | +0.07 | +0.1% | $97.73 | $99.28 | $95.38 | 730,800 | |
| $98.24 | -1.03 | -1.0% | $99.27 | $100.02 | $96.47 | 696,400 | |
| $99.27 | +0.44 | +0.4% | $100.44 | $101.85 | $98.69 | 499,900 | |
| $98.83 | +1.12 | +1.1% | $98.47 | $100.76 | $97.54 | 613,600 | |
| $97.71 | -1.31 | -1.3% | $99.36 | $99.36 | $96.88 | 1,124,800 | |
| $99.02 | +1.01 | +1.0% | $101.17 | $102.00 | $98.80 | 617,700 | |
| $98.01 | +1.24 | +1.3% | $97.69 | $100.85 | $97.06 | 921,400 | |
| $96.77 | -5.67 | -5.5% | $101.66 | $101.66 | $96.14 | 914,300 | |
| $102.44 | -2.27 | -2.2% | $105.27 | $105.93 | $101.09 | 789,700 | |
| $104.71 | +2.51 | +2.5% | $102.96 | $106.57 | $102.25 | 573,700 | |
| $102.20 | +1.14 | +1.1% | $99.88 | $102.89 | $99.88 | 422,900 | |
| $101.06 | -0.74 | -0.7% | $100.23 | $101.77 | $99.83 | 478,600 | |
| $101.80 | -0.94 | -0.9% | $100.58 | $103.31 | $99.41 | 513,000 | |
| $102.74 | -2.15 | -2.0% | $103.53 | $105.71 | $101.25 | 466,900 | |
| $104.89 | -0.53 | -0.5% | $106.08 | $106.08 | $103.90 | 269,800 | |
| $105.42 | +0.68 | +0.6% | $105.50 | $108.57 | $103.95 | 455,600 | |
| $104.74 | -1.39 | -1.3% | $105.79 | $108.43 | $104.09 | 332,000 | |
| $106.13 | -1.04 | -1.0% | $106.01 | $108.85 | $103.98 | 775,200 | |
| $107.17 | -5.36 | -4.8% | $110.21 | $114.75 | $107.09 | 441,200 | |
| $112.53 | +0.66 | +0.6% | $111.21 | $113.97 | $110.03 | 311,100 | |
| $111.87 | -1.48 | -1.3% | $113.21 | $114.75 | $111.35 | 359,000 | |
| $113.35 | +1.91 | +1.7% | $112.73 | $114.07 | $111.79 | 352,500 | |
| $111.44 | +1.44 | +1.3% | $112.29 | $113.60 | $109.89 | 400,600 | |
| $110.00 | +1.08 | +1.0% | $109.38 | $112.59 | $106.58 | 523,100 | |
| $108.92 | -6.81 | -5.9% | $114.51 | $114.61 | $108.73 | 568,600 |
- Ticker
- NASDAQ:RYTM
- Asset type
- Stock
- Sector
- Health care
- Industry
- Pharmaceuticals
- Exchange
- NASDAQ
- Currency
- USD
What changed lately
Latest news release · Nov 16, 2026
Rhythm Pharmaceuticals Announces Presentation of New Data at ObesityWeek® 2026
Latest earnings call · Nov 3, 2026
Rhythm Pharmaceuticals (NASDAQ:RYTM) Q3 2026 Earnings Call
Replay and transcript
Latest deck · Nov 3, 2026
Q3 2026 Earnings Presentation
Earnings · 29 slides
Calls
Replays
Rhythm Pharmaceuticals (NASDAQ:RYTM) Q3 2026 Earnings Call
Tue, Nov 03, 2026 · 8:00 AM ET
Watch TranscriptRhythm Pharmaceuticals (NASDAQ:RYTM) Q2 2026 Earnings Call
Tue, Aug 04, 2026 · 8:00 AM ET
Watch TranscriptRhythm Pharmaceuticals (NASDAQ:RYTM) Q1 2026 Earnings Call
Tue, May 05, 2026 · 8:00 AM ET
Watch Transcript
Latest news
Rhythm Pharmaceuticals Announces Presentation of New Data at ObesityWeek® 2026
Nov 16, 2026
Closed $116.61 (+8.5%) on Nov 17, 2026
Rhythm Pharmaceuticals Announces NICE Guidance for IMCIVREE® (Setmelanotide) Updated to Include Adults Living with Bardet-Biedl Syndrome
Nov 4, 2026
Closed $110.68 (+28.0%) on Nov 4, 2026
Rhythm Pharmaceuticals Reports Third Quarter 2026 Financial Results and Business Update
Nov 3, 2026
Closed $86.44 (-7.5%) on Nov 3, 2026
Rhythm Pharmaceuticals and LG Chem Enter into Amendment to Bivamelagon Exclusive License Agreement
Nov 2, 2026
Closed $86.44 (-7.5%) on Nov 3, 2026
Rhythm Pharmaceuticals to Report Third Quarter 2026 Financial Results on Tuesday, November 3, 2026
Oct 21, 2026
Closed $88.62 (-1.8%) on Oct 21, 2026
Rhythm Pharmaceuticals Announces Commercial Launch of IMCIVREE® (setmelanotide) in Japan for Patients with Acquired Hypothalamic Obesity
Oct 13, 2026
Closed $86.71 (+0.1%) on Oct 14, 2026
Rhythm Pharmaceuticals Announces Health Canada Approval of IMCIVREE® (setmelanotide) for Weight Management in Adult and Pediatric Patients 4 years of Age and Older with Acquired Hypothalamic Obesity
Sep 22, 2026
Closed $99.27 (+0.4%) on Sep 22, 2026
Rhythm Pharmaceuticals Announces New Data Presentations at the European Society for Paediatric Endocrinology Meeting
Sep 10, 2026
Closed $102.20 (+1.1%) on Sep 10, 2026
Rhythm Pharmaceuticals Announces MHLW Approval of IMCIVREE® (setmelanotide) for Patients with Acquired Hypothalamic Obesity (HO) in Japan
Aug 24, 2026
Closed $111.44 (+1.3%) on Aug 24, 2026
Rhythm Pharmaceuticals Announces Appointment of Manher (AJ) Joshi as Chief Medical Officer
Aug 17, 2026
Closed $115.44 (0.0%) on Aug 17, 2026
Financings
Public offering of common stock
Jul 10, 2025
Made bigger: about US$175M · US$85 a share · Morgan Stanley +5
Dealers: Morgan Stanley (co-lead), BofA Securities (co-lead), Stifel (co-lead), Wells Fargo Securities (co-lead), Canaccord Genuity, Citizens Capital Markets
At-the-market programme of common stock
Feb 26, 2025
Closed: US$75M raised · US$56.3 a share
Decks
Q3 2026 Earnings Presentation
Earnings · 29 slides · Nov 3, 2026
64th Annual Meeting of the European Society for Paediatric Endocrinology (ESPE) 2026
Conference · 16 slides · September 2026
64th Annual Meeting of the European Society for Paediatric Endocrinology (ESPE) 2026
Conference · 13 slides · September 2026
Investor Presentation (September 2026)
Investor deck · 66 slides · September 2026
Rhythm Pharmaceuticals, Inc. on 6ix
- Sector
- Health care
- Industry
- Pharmaceuticals
- News releases
- 37 in the last 12 months · 225 in all · newest Nov 16, 2026 · oldest 2019
- Calls
- 22 calls with a replay · 22 with a transcript · latest Nov 3, 2026
- Decks
- 61 decks · latest Nov 3, 2026
Where Rhythm Pharmaceuticals, Inc. is listed
| Listing | Exchange | Country | Currency |
|---|---|---|---|
| NASDAQ:RYTM · Home listing · This page | NASDAQ | United States | USD |
| LS Exchange:A2H5A0 | LS Exchange | Germany | EUR |
| Lang & Schwarz:A2H5A0 | Lang & Schwarz | Germany | EUR |
| gettex:1RV | gettex | Germany | EUR |
| Tradegate:1RV | Tradegate | Germany | EUR |
| BMV:RYTM | BMV | Mexico | MXN |
| BOATS:RYTM | BOATS | United States | USD |
| Frankfurt:1RV | Frankfurt | Germany | EUR |
| BIVA:RYTM | BIVA | Mexico | MXN |
| Dusseldorf:1RV | Dusseldorf | Germany | EUR |
| Munich:1RV | Munich | Germany | EUR |
| Stuttgart:1RV | Stuttgart | Germany | EUR |
| Xetra:1RV | Xetra | Germany | EUR |
Log in to ask 6ix AI your own questions about Rhythm Pharmaceuticals, Inc.